Showing results (11-20 of 32) with videos related to

Sort By:
Pageof 4
Transplantation and Cellular Therapy|June 4, 2025
Pilot Study of Low-Dose Splenic Irradiation and Transplantation in JAK Inhibitor-Refractory Myelofibrosis With SplenomegalyKristin Rathje, Nico Gagelmann, Artur Schneider, et al.
Multiple Sclerosis and Related Disorders|January 4, 2024
Benefits of aHSCT over alemtuzumab in patients with multiple sclerosis besides disability and relapses: Sustained improvement in cognition and quality of lifeBente Braun, Felix Fischbach, Johanna Richter, et al.
Rheumatology (Oxford, England)|April 23, 2025
A novel approach to refractory idiopathic inflammatory myopathy: CD19 CAR T-cell therapy-case report and literature reviewIsabell Haase, Johanna Richter, Marie-Therese Holzer, et al.
Mbio|December 17, 2024
Characterization of a novel covS SNP identified in Australian group A Streptococcus isolates derived from the M1UK lineageJohanna Richter, Amanda J Cork, Yvette Ong, et al.
Mbio|March 12, 2020
Vaccine-Induced Th1-Type Response Protects against Invasive Group A Streptococcus Infection in the Absence of Opsonizing AntibodiesTania Rivera-Hernandez, Mira Syahira Rhyme, Amanda J Cork, et al.
Haematologica|March 20, 2025
Lower incidence of chronic graft-versus-host disease after ruxolitinib plus extracorporeal photopheresis versus ruxolitinib alone in steroid-refractory acute graft-versus-host disease following allogeneic stem cell transplantationIryna Lastovytska, Silke Heidenreich, Evgeny Klyuchnikov, et al.
Bone Marrow Transplantation|February 6, 2024
Graft-versus-host disease and impact on relapse in myelofibrosis undergoing hematopoietic stem cell transplantationSofia Oechsler, Nico Gagelmann, Christine Wolschke, et al.
Bone Marrow Transplantation|November 27, 2025
Comparison of anti-human T cell globulins on immune reconstitution and early infections after autologous transplant in patients with multiple sclerosisJohanna Richter, Nico Gagelmann, Felix Fischbach, et al.
Med (New York, N.Y.)|March 30, 2024
CD19-targeted chimeric antigen receptor T cell therapy in two patients with multiple sclerosisFelix Fischbach, Johanna Richter, Lena Kristina Pfeffer, et al.
European Journal of Haematology|September 20, 2024
Comparable Results Between 8 and 12 Gray TBI in Combination With Fludarabine and Post-Transplant Cyclophosphamide in MRD-Negative but Not in MRD-Positive Acute Lymphoblastic Leukemia Patients Transplanted in First Complete RemissionNormann Steiner, Radwan Massoud, Johanna Richter, et al.
Pageof 4